mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |